Earnings

ABM Industries Inc (ABM) Misses Q1 EPS Estimates

ABM Industries Inc (ABM) Misses Q1 EPS Estimates

ABM Industries Inc (ABM) reported Q1 2026 gaap earnings of $0.83 per share, missing the $0.87 consensus estimate (miss by…

Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin

Nio Inc (NIO) delivered Q4 2025 gaap earnings of $0.29 per share, surpassing analysts' $0.05 forecast (beat by 441.4%). Top-line…

Priority Technology Holdings, Inc (PRTH) Reports Q4 Earnings

Priority Technology Holdings, Inc (NASDAQ:PRTH) reported fourth quarter 2025 financial results. Q4 2025 adjusted earnings at Priority Technology Holdings, ...

Q32 Bio Inc. (QTTB) Reports Q4 Earnings

Q32 Bio Inc. (QTTB) reported Q4 2025 adjusted earnings of $3.65 per share. No consensus estimate was available for comparison.…

Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year

Cullinan Therapeutics posts $0.73 per share loss in Q4 2025, matching year-ago results as the pre-revenue biotech maintains clinical development…

Tenax Therapeutics Inc (TENX) Reports Q4 Earnings

**Tenax Therapeutics Reports Q4 2025 Results**

Opus Genetics Inc. (IRD) Reports FY25 Earnings

**BREAKING: Opus Genetics Inc. Reports Q4 2025 Results**

Apyx Medical (APYX) Q4 Revenue Jumps 34.8% to $19.2M, Loss Narrows to $0.06/Share

Apyx Medical narrows Q4 loss to $0.06 per share as revenue surges 34.8% year-over-year to $19.2 million, with fiscal 2026…

Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings

**Cullinan Therapeutics Inc Reports Q4 2025 Results**

Prelude Therapeutics Inc (PRLD) Reports Wider Loss for FY25 vs. Estimates

**BREAKING: Prelude Therapeutics Reports Wider-Than-Expected Q4 Loss**